Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2020 | Ruxolitinib in 2020 and beyond

Aaron Gerds, MD, Cleveland Clinic, Cleveland, OH, discusses the use and impact of ruxolitinib for treating patients with myeloproliferative neoplasms (MPNs). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).